Multiple Sclerosis News TodayMyelin-producing Brain Cells Regenerated Using Stem Cells in Early StudyMultiple Sclerosis News TodayResearchers, using two different kinds of stem cells in rats, were able to regenerate oligodendrocytes — myelin-producing … Continue reading
European Biotechnology |
Another death related to allogenic CAR–T cell therapy
European Biotechnology Following the death of a patient with blastic plasmacytoid dendritic cell neoplasm (BPDCN), the FDA put a hold on two clinical Phase I trails with UCART123, French Cellectis SA’s allogenic CAR–T therapies. Preliminary results from two trials in CD19+ … |
Scientific American |
Mail-Order CRISPR Kits Allow Absolutely Anyone to Hack DNA …
Scientific American Experts debate what amateur scientists could accomplish with the powerful DNA editing tool—and whether its ready availability is cause for concern. Study shows CRISPR can reverse mutations – The Johns Hopkins …Johns Hopkins News-Letter Potential Parkinson’s Treatment Seen in New Version of Gene …Parkinson’s News Today Syngenta obtains non-exclusive IP license from Broad Institute for …Digital Journal HDBuzz all 6 news articles » |
Scientific American |
Mail-Order CRISPR Kits Allow Absolutely Anyone to Hack DNA
Scientific American CRISPR–Cas9 (or CRISPR, for short) has given scientists a powerful way to make precise changes to DNA—in microbes, plants, mice, dogs and even in human cells. The technique may help researchers engineer drought-resistance crops, develop better … Study shows CRISPR can reverse mutationsJohns Hopkins News-Letter Potential Parkinson’s Treatment Seen in New Version of Gene …Parkinson’s News Today Syngenta obtains non-exclusive IP license from Broad Institute for …Digital Journal HDBuzz all 6 news articles » |
European Biotechnology |
Another death related to allogenic CAR–T cell therapy
European Biotechnology Following the death of a patient with blastic plasmacytoid dendritic cell neoplasm (BPDCN), the FDA put a hold on two clinical Phase I trails with UCART123, French Cellectis SA’s allogenic CAR–T therapies. Preliminary results from two trials in CD19+ … |
|
Space station will host stem cells for heart research
Emory News Center Researchers at Emory University School of Medicine and Children’s Healthcare of Atlanta have been using space-simulation machines to enhance the ability of pluripotent stem cells to turn into cardiac muscle cells. Now they – or the cells they’ve … |
|
Space station will host stem cells for heart research
Emory News Center Researchers at Emory University School of Medicine and Children’s Healthcare of Atlanta have been using space-simulation machines to enhance the ability of pluripotent stem cells to turn into cardiac muscle cells. Now they – or the cells they’ve … |